PubMed: Cannabis for psychiatric disorders – Has The Pendulum Swung Too Far?
Asian J Psychiatr. 2021 Dec 28;69:102995. doi: 10.1016/j.ajp.2021.102995. Online ahead of print.
Strong interest in cannabinoids as potential treatment for psychiatric disorders has led to numerous studies. Particularly, cannabidiol (CBD) has promise as a pharmacotherapy for psychotic disorders as well as anxiety disorders. Herein we shed some light on therapeutic potential while examining extant evidence. Literature is still nascent. This should be balanced against the ubiquitous use of cannabis in patients with psychiatric disorders that has been strongly tied to frequent relapses and heightened violence.
#CBD #Hemp https://pubmed.ncbi.nlm.nih.gov/34974321/?utm_source=Chrome&utm_medium=rss&utm_campaign=None&utm_content=1jYCQzi_o_qLYr-oQfnMhShgOXkvGma3vcnBGJtrBhuJMOvEVJ&fc=None&ff=20220103055847&v=2.17.5 January 2, 2022 11:00 am